[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"home-monitoring-follow-up\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:home-monitoring-follow-up":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,79],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100586868","stop-sepsis-through-home-monitoring-cooperative-100586868",false,"NCT06920979","Stop Sepsis Through Home Monitoring Cooperative","Stethoscoop","Inclusion Criteria:\n\n* This study will include patients aged 18 years or older, capable of giving informed consent, presenting with signs of severe acute infection with a risk of developing sepsis at the emergency department or at their primary care physician.\n\nExclusion Criteria:\n\n* Patients that are severely ill and require immediate hospitalization Qucik Sepsis Related Organ Failure score (QSOFA) ≥ 1 National Early Warning Score (NEWS) ≥ 5\n* Patients that demonstrate confusion, changes in mental state and\u002For an Mini-Mental State Examination (MMSE) below 26\n* Presence of neuropenic fever\n* Patients currently undergoing immunosuppressive therapy or chemotherapy\n* Patients with human immunodeficiency virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS)\n* Suspicion of appendicitis, suspicion of meningitis or meningeal irritation, suspicion of or high risk of developing endocarditis\n* Complicated operation wounds at the time of screening\n* Proven pneumonia (CURB 65 score ≥ 1)\n* Emphysema, Chronic Obstructive Pulmonary Disease (COPD) GOLD \\>1 or interstitial lung disease\n* Patients with oxygen at home \\> 2 l\u002Fmin on a chronic basis (severe underlying lung disease?)\n* Severe cardiovascular disease including:\n\n  * Severe heart failure New York Heart Association (NYHA) class \\> 1\n  * Endoprosthesis\n  * Cardiac arrhythmia including atrial fibrillation\n  * Severe heart valve abnormalities\n  * Mechanic valve replacement\n  * Recent acute myocardial infarct or coronarography (less than 1y ago)\n  * Severe peripheral vascular morbidity\n* Acute chest pain (suspicion of acute coronary pathology)\n* Suspicion of\u002Fchance of septic arthritis","ALL","18 Years",{"count":19,"type":20},120,"ESTIMATED","INTERVENTIONAL",[23],"NA","In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.",[26,27,28,29],"Sepsis","Home Monitoring Follow-up","Infection","Innovativeness","RECRUITING","2026-04-27",{"date":33,"type":34},"2026-05-01","ACTUAL",{"date":36,"type":34},"2025-02-01",{"date":38,"type":20},"2028-12-31",{"name":40,"class":41},"University Hospital, Antwerp","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":16,"minAge":17,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":61,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":4},"100613770","the-effect-of-a-gender-education-program-based-on-the-com-b-model-developed-for-newlywed-couples-and-home-monitoring-on-individuals-and-families-100613770","NCT07270913","The Effect of a Gender Education Program Based on the Com-B Model Developed for Newlywed Couples and Home Monitoring on Individuals and Families","Inclusion Criteria:\n\n* Married 1 month ago\n* The woman and her husband are literate in Turkish\n* Being a housewife\n* Growing up in Şanlıurfa and residing in the center\n* Authorizing participation.\n\nExclusion Criteria:\n\n* \\- Married for more than 1 month or single\n* Being a working woman\n* Not knowing Turkish\n* Not living in the center of Şanlıurfa\n* Currently participating in any other intervention program",true,"40 Years",{"count":52,"type":20},200,[23],"Introduction and Aims:\n\nThe family, recognized as the smallest and most powerful social unit that forms society, is an arena where gender roles, gender identities, and inequalities are reproduced and developed. The establishment, maintenance, and continuation of a healthy marriage is the source of healthy families and, naturally, healthy individuals. Therefore, research on newly married individuals is valuable as it sheds light on future generations. This research began with the question, \"How should effective gender education be designed to minimize gender inequality and the problems arising from it?\" This research presents a study protocol to evaluate the effectiveness of a gender education program based on the Capacity, Opportunity, and Motivation to Behave (COM-B) model. Furthermore, this study aims to take solid steps in the first stage of family formation through a one-year follow-up of newly married couples and thus create healthy and strong families.\n\nMethod:\n\nThis study will be conducted as a two-phase, prospective, single-center, two-group (1:1) parallel design, pre-test-post-test randomized controlled trial. The Capacity, Opportunity, and Motivation Behavior (COM-B) model is a theoretical framework consisting of six components to understand and support behavior change. In the first phase, a gender education program based on the COM-B model (COMBTC) will be developed, and in the second phase, the effectiveness of COMBTC will be evaluated with 100 newly married couples. The sample will consist of 100 couples who have been married for no more than one month and live in central Şanlıurfa, divided into intervention and control groups at a 1:1 ratio. Participants in the intervention group will undergo a 3-week, multi-component education program based on the COM-B model, while participants in the control group will receive routine general advice. Assessments will be conducted at baseline, after the education, and at 6-11 months. Research data will be collected using a personal information form, a healthy family scale, a marital role expectations scale, a marital problem-solving scale, and a family harmony scale. The data will be evaluated using descriptive statistical analyses and relevant tests.",[56,57,58,27,59,60],"Newly Married Couples","Gender Equality","COM_B Model","Family Dynamics","Education",[62,63,64,65,66,67,68],"Gender","COM-B Model","Behavior Change","Newly married couples","Family Health","Home monitoring","Family harmony","NOT_YET_RECRUITING","2025-11-26",{"date":72,"type":34},"2025-12-08",{"date":74,"type":20},"2026-01",{"date":76,"type":20},"2027-02",{"name":78,"class":41},"Selma Kahraman",{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":87,"targetDuration":89,"studyType":90,"phases":4,"briefSummary":91,"conditions":92,"keywords":95,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":107,"leadSponsor":109,"locationsCount":42},"100582577","home-based-clinical-management-of-cardiac-complications-in-systemic-sclerosis-100582577","NCT06865118","Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis","The Nor-SSCardioCare Pilot Trial: Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis Patients","Nor-SScCare","Inclusion Criteria:\n\n* Fulfilment of the 2013 American College of Rheumatology\u002FEuropean Alliance of Associations for Rheumatology (ACR\u002FEULAR) SSc classification criteria\n* Fulfilment of the 2022 hemodynamic definition of PAH (mean pulmonary arterial pressure (mPAP) \\>20 mmHg, pulmonary artery wedge pressure (PAWP) ≤15 mmHg, and pulmonary vascular resistance (PVR) \\>2 WU) in the absence of other causes of pre-capillary PH (no significant ILD and no clinical suspicion of pulmonary or left sided heart disease as the predominant cause of PH), independent of diagnostic period and previous treatment\n* Participants must be able to understand and follow trial procedures including completion of questionnaires regarding Patient Reported Outcome measures\n* Participants must have access to the internet, and experience in using smartphones or other electronic devices with internet access.\n* Capable of giving signed informed consent\n\nExclusion Criteria:\n\n* Severe end organ disease\n\n  1. Severe heart failure with EF \\\u003C 30%\n  2. End stage kidney disease with eGFR \\\u003C 30 mL\u002Fmin\n  3. End stage lung disease with FVC \\\u003C 50% or coexisting severe lung diseases (e.g., COPD (including emphysema), GOLD grade 3-4 with FEV1 \\\u003C50%)\n  4. In the opinion of the investigator, other clinically significant pulmonary abnormalities\n* Active treatment for cancer or non-curable cancer\n* Contraindications for functional assessment (6MWD and 1MSTS):\n\n  1. Uncontrolled systemic hypertension (systolic \\>220 mmHg or diastolic \\>120 mmHg) or hypotension (systolic \\\u003C90 mmHg), resting tachycardia (\\>130 beats per minute).\n  2. Surgery, myocardial infarction\u002Funstable angina, pneumothorax or stroke within the past 8 weeks.\n  3. Severe musculoskeletal or neurological limitations preventing safe ambulation or any acute illness which might impair performance or safety in the opinion of the investigator.\n* Unable to speak, write and read Norwegian\n* Pregnancy or planned pregnancy",{"count":88,"type":20},20,"12 Weeks","OBSERVATIONAL","The goal of this observational pilot trial is to evaluate the feasibility of home monitoring for patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). The study will assess home-based measures that may help detect disease progression earlier and will also evaluate patient satisfaction, usability, and the impact on health-related quality of life.\n\nThe study aims to answer:\n\n* How feasible is home monitoring in SSc-PAH patients in terms of adherence, technical feasibility, and validity of home-based measures?\n* How do home-based assessments compare to hospital-based assessments in detecting disease progression?\n* How do patients experience digital home monitoring?\n\nParticipants will:\n\n* Use a digital platform (Zeen Health) for biweekly self-reporting of symptoms and physiological measurements.\n* Perform functional tests at home, including the 1-minute sit-to-stand test (1MSTS).\n* Wear the ECG247 Smart Heart Sensor for one week to monitor heart rhythm.\n* Collect and submit home blood samples every two weeks.\n* Attend two hospital visits (baseline and week 12) for clinical assessments, functional testing, pulmonary function tests, echocardiography, and routine blood sampling for clinical assessments.\n\nThis 12-week study will assess the feasibility of home monitoring, as well as the validity and reliability of home-based measures. The findings will help design a future study aimed at integrating home-based assessments into routine clinical care.",[93,94,27],"Systemic Sclerosis (SSc)","Pulmonary Arterial Hypertension (PAH)",[96,97,67,98,99,100,101,102],"Systemic Sclerosis","Pulmonary arterial hypertension","Remote monitoring","Observational study","PAH progression","Disease progression","Home-based markers","2025-03-16",{"date":105,"type":34},"2025-03-19",{"date":103,"type":34},{"date":108,"type":20},"2025-07",{"name":110,"class":41},"Oslo University Hospital"]